and it eventually selected 80 pregnant women for the final experiment. Those pregnant women who had preeclampsia, intrahepatic cholestasis during pregnancy, placenta previa or chorioamnionitis were more likely to experience pre-term birth. A patient interview was conducted in a detailed manner and all the necessary information regarding the mother and the infant were collected to carry out the study. Among 80 patients, collected the highest number of 39 cases i.e. 49% in between the age group of 17-23 years and the least number of cases therefore 19 i.e. 24% in between the age group of 35-45 years. We studied that maternal variable such as social status and educational status also impacts deliveries. Alcoholics had the highest number of very pre-term deliveries i.e., 36.25%. And among undergraduates, moderate preterm deliveries were a predominant number, i.e. 38.75%. Among the cases collected, 22.5% of women who have previous abortions had the highest number of preterm births with 31 cases and 5% of women with thyroid had the least number of pre-term births. 41% of preemie births were observed in the gestational gap of < 18 months, while 24% were recorded in > 30 months. In between two types of deliveries, 69% of preemie births were observed in the cesarean section and normal delivery includes 31%. The results of our study reveal that there is a need to assess the causes and complications among pregnant women who are at risk of delivering a premature baby. We have concluded that counseling the patients about their risk factors is necessary, and the patients should be told that harmful social habits will have a huge impact on their baby, before or after the delivery.

The objective of the study is to compare and evaluate the efficacy of atorvastatin (group -A) versus rosuvastatin (group -B) on baseline parameters like lipid profile tests and to assess the risk of metabolic syndrome using a Mets calculator. A total of 100 patients were enclosed in the present study who met the inclusion criteria. They were divided into two groups based on their treatment plan Group A includes 24 males and 26 females while Group B includes 23 males and 27 females. The mean differences before treatment for group A and group B are as follows, HDL ( 31.52±0.35 and 28.34±0.480), LDL (161.4±1.09 and 163.16±0.94), Total cholesterol (252.82±1.09 and 255.56±1.26) and Triglycerides (214.2±0.86 and 215.98±0.62), VLDL (35.98±0.56 and 36.12±0.43). The mean differences after treatment for group A and group B are as follows HDL (39.92±0.46 and 42.04±0.30), LDL (144.96±0.68 and 138.34±0.73), Total cholesterol (181.48±1.98 vs 174.32±2.08), Triglycerides (185.94±1.22 vs 181.74±1.77), VLDL (27.14±0.21 and 24.72±0.27).Group B (P=0.001) exhibited a significantly greater reduction in cholesterol levels as compared to Group A (P = 0.002). The reductions in LDL, VLDL, Total Cholesterol, and Triglycerides along with increased HDL levels were found to be significantly more in the Rosuvastatin group. In this study, we observed that patients on Rosuvastatin exhibited better control over lipid profile when compared to patients who are on Atorvastatin. Since, this study was conducted on a smaller number of patients, to make consecutive remarks about the superiority of either of the treatment regimen; further analysis of clinical trials is required for appropriate selection of the best statin therapy.

The study aimed to assess established and non-established risk factors and drug therapy problems in the cardiology department and perform a Prospective Observational Study. The study was conducted for a period of 6 months from September 2019 to February 2020 in 200 patients with established heart diseases attending a tertiary care hospital in the cardiology department. A patient interview was conducted using an evaluation form. Among 100 patients with established cardiovascular diseases that were engaged in this study, a high number of patients were males and the majority of the patients were in the age group 'Between' 41-60 years. This study shows smoking and alcohol consumption is the most common risk factors in males, hypertension was the mainly 'established' risk factor for cardiovascular disease followed by Angina and Myocardial infarction. Among non-established risk factors, CKD was the main risk factor in cardiovascular disease followed by cardiovascular accidents. ACE Inhibitors and BB are the drugs mainly used in cardiovascular diseases followed by statins and diuretics. This study throws light on the statistical evidence among the age group and gender risk factors, and drug utilization. In the course of this study use of drug pattern was as follows: Anticoagulants are used in (29%) patients, ACE in (22.5%) patients, Antiplatelets in (68%) patients, diuretic in (34%) patients, Statins in (57%) patients, BB in (67.5%) patients, PPI in (22%) patients, CCB in (19.5%) patients, Nitrates (26.5%) patients, OHA (25%) patients. Similar findings in other studies (Blessy Rachel Thomas) (26) on drug therapy usage were found. There is a need to assess both nonestablished and established risk factors among patients with established heart diseases as in this study, CKD and HTN were the most common peril and counsel patients about their risk factors and social habits and lifestyle changes. There is a need for a clinical pharmacist to counsel about lifestyle changes and assess drug therapy utilization patterns in cardiac patients.

Cirrhosis is a late-stage liver disease in which/ advanced stage of scaring and conditions, such as hepatitis and chronic alcoholism. This disease is a condition in which your liver is scarred and permanently damaged. Scar tissue replaces healthy liver tissue and prevents your liver from working normally. Irreversible change in the normal liver tissue results in the degeneration of functioning liver cells and their replacement with fibrous connective tissue. In the present study, the risk assessment in alcoholic patients is assessed using laboratory data. Other biochemical parameters and severity are assessed using the child-pugh score. In the present study, 98 patients were identified of which 8 patients were excluded due to various reasons, and 90 patients' data were analyzed. In order to assess the risk of cirrhosis in alcoholic patients, we used the cpugh score for assessing the severity and survival rate of subjects. A total of 90 patients were enrolled in this observational study. The study confirmed that more than 60 % of the subjects possess a severe risk of cirrhosis and risk factors such as age, gender, ALD, high BMI, social history family history, and encephalopathy. Article info

The purpose of the study was to evaluate the prevalence, comorbidities, pharmacological therapy, and effectiveness of common lifestyle changes for metabolic dysfunction in women with the polycystic ovarian syndrome (PCOS) and related comorbidities in the gynaecology division. This 6-month prospective observational study of 120 PCOS patients who were gynaecology patients at a tertiary care hospital was conducted from September 2021 to February 2022. An interview with the patient was done using an assessment form. This study highlighted the supportive evidence among PCOS patients for the advantages of changing one's lifestyle. This study involved 90 PCOS individuals out of a total of 120 participants, many of them were in the 20-30 age group. This research analyses the high prevalence of cardiovascular disease comorbidities and demonstrates that a high BMI is the most common risk factor for PCOS. The findings of our study indicate the necessity of evaluating the complications seen in individuals who are at risk, such as infertility. This line of research demonstrates the critical impact that medication and lifestyle modifications play in managing PCOS. Patients with the polycystic ovarian syndrome should get advice regarding lifestyle modifications from a clinical pharmacist. Article info